Elixir Medical announced three-year results from a large randomized controlled trial of its DynamX coronary bioadaptor system.

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Clinical follow-up will continue through five years. BIOADAPTOR RCT trial is the third trial of Elixir Medical’s robust DynamX® bioadaptor clinical evidence program consisting of nine company ...

Intravascular lithotripsy is quickly gaining the attention of the medtech industry’s giants. Yet distinguishing its true ...

Abbott's Tendyne transcatheter mitral valve replacement (TMVR) system was approved by the FDA and indicated for those with ...

"With these results, we are pleased to demonstrate that restoring hemodynamic modulation of the artery translates to lasting clinical outcomes, elevating the level of care for patients,” said Motasim ...

The FDA has shared multiple recalls of allergy medicine in 2025 — here are the products that companies are pulling from their ...

Explore the benefits of hair growth oils for density, length, and hair health. We spoke to experts to reveal how long it ...

CEO Rick Piccolo says this diversification brings in $3.5 million and has allowed the airport to weather downturns and fund ...

Recovering after any music festival, but especially Glastonbury, means more than simply bouncing back on your feet. Instead, ...

The 10,000-step goal originated from a 1960s Japanese advertising campaign for the world’s first commercial pedometer ...

Importantly, walking has a halo of benefits beyond physical health. It can help with brain activity, doubling creative idea ...